MESENCHYMAL CHONDROSARCOMA
Clinical trials for MESENCHYMAL CHONDROSARCOMA explained in plain language.
Never miss a new study
Get alerted when new MESENCHYMAL CHONDROSARCOMA trials appear
Sign up with your email to follow new studies for MESENCHYMAL CHONDROSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare bone cancer: trabectedin trial targets advanced disease
Disease control Recruiting nowThis study tests the drug trabectedin in 16 people aged 16 and older with advanced mesenchymal chondrosarcoma, a rare bone cancer that has spread or cannot be removed by surgery. Participants must have already tried at least one chemotherapy. The goal is to see if trabectedin can…
Matched conditions: MESENCHYMAL CHONDROSARCOMA
Phase: PHASE2 • Sponsor: Italian Sarcoma Group • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Scientists hunt for better ways to diagnose and treat rare bone tumors
Knowledge-focused Recruiting nowThis study looks at 300 people with cartilage tumors, including both benign types and the cancer chondrosarcoma. Researchers are studying genetic changes and molecules called miRNAs to better tell these tumors apart and predict outcomes. The goal is to improve diagnosis and find …
Matched conditions: MESENCHYMAL CHONDROSARCOMA
Sponsor: St. Anne's University Hospital Brno, Czech Republic • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC